Real-World Data Question Low-Dose Steroid Use in Vasculitis
Patients with ANCA-associated vasculitis receiving low glucocorticoid doses as per the PEXIVAS trial faced an increased risk for death, renal failure, progression, or relapse in this real-world study.
Medscape Medical News
source https://www.medscape.com/viewarticle/real-world-data-question-low-dose-steroid-use-vasculitis-2024a1000mm6?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/real-world-data-question-low-dose-steroid-use-vasculitis-2024a1000mm6?src=rss
Comments
Post a Comment